Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-05-30
1991-08-20
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546172, 546174, 546175, 546176, C07D40110, C07D40310, A61K 3147
Patent
active
050414534
ABSTRACT:
This invention relates to certain quinolinyl-benzoheterobicyclic compounds and their use as valuable pharmaceutical agents, particularly as lipoxygenase inhibitors and/or leukotriene antagonists and/or as mediator release inhibitors useful as anti-inflammatory and anti-allergic agents.
REFERENCES:
patent: 4186201 (1980-01-01), Erickson
patent: 4851409 (1989-07-01), Young et al.
patent: 4920131 (1990-04-01), Huang et al.
patent: 4946855 (1990-08-01), Yoshiuaga et al.
Gavai Ashvin V.
Huang Fu-chih
Learn Keith S.
Balogh Imre (Jim)
Nicholson James A.
Rhone-Poulenc Rorer Pharmaceuticals Inc.
Savitzky Martin F.
Springer David B.
LandOfFree
Quinolinyl-benzoheterobicyclic derivatives as antagonists of leu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinolinyl-benzoheterobicyclic derivatives as antagonists of leu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinolinyl-benzoheterobicyclic derivatives as antagonists of leu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1008244